Department of Energy, Environmental and Chemical Engineering, Washington University in St. Louis, St. Louis, MO, 63130, USA.
Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, 63130, USA.
Biotechnol J. 2020 Oct;15(10):e1900319. doi: 10.1002/biot.201900319. Epub 2020 Jan 7.
Engineered microbes are exciting alternatives to current diagnostics and therapeutics. Researchers have developed a wide range of genetic tools and parts to engineer probiotic and commensal microbes. Among these tools and parts, biosensors allow the microbes to sense and record or to sense and respond to chemical and environmental signals in the body, enabling them to report on health conditions of the animal host and/or deliver therapeutics in a controlled manner. This review focuses on how biosensing is applied to engineer "smart" microbes for in vivo diagnostic, therapeutic, and biocontainment goals. Hurdles that need to be overcome when transitioning from high-throughput in vitro systems to low-throughput in vivo animal models, new technologies that can be implemented to alleviate this experimental gap, and areas where future advancements can be made to maximize the utility of biosensing for medical applications are also discussed. As technologies for engineering microbes continue to be developed, these engineered organisms will be used to address many medical challenges.
工程微生物是当前诊断和治疗方法的令人兴奋的替代方法。研究人员已经开发出广泛的遗传工具和部件来设计益生菌和共生微生物。在这些工具和部件中,生物传感器允许微生物感知和记录或感知和响应体内的化学和环境信号,使它们能够报告动物宿主的健康状况和/或以受控的方式提供治疗。本综述重点介绍了如何将生物传感应用于工程“智能”微生物,以实现体内诊断、治疗和生物遏制目标。从高通量体外系统过渡到低通量体内动物模型时需要克服的障碍、可以实施的新技术来缓解这种实验差距,以及可以在哪些方面取得未来进展以最大限度地提高生物传感在医学应用中的实用性等方面也进行了讨论。随着微生物工程技术的不断发展,这些工程生物将被用于解决许多医学挑战。